Magic mushroom drug tested in seniors for safety
NCT ID NCT07516405
First seen Jun 27, 2026 · Last updated Aug 11, 2026 · Updated 6 times
Summary
This study is testing whether psilocybin, the active ingredient in magic mushrooms, is safe and tolerable for healthy adults aged 65 to 85. Researchers will monitor side effects and how the drug moves through the body. The goal is to gather safety data, not to treat any disease.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY VOLUNTEER are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Dana-Farber Cancer Institute
RECRUITINGBoston, Massachusetts, 02215, United States
Contact Email: •••••@•••••
-
Emory University Brain Health Center
RECRUITINGAtlanta, Georgia, 30329, United States
Contact Email: •••••@•••••
-
New York University Langone Health, Center for Psychedelic Medicine
NOT_YET_RECRUITINGNew York, New York, 10016, United States
-
University of California San Francisco (UCSF) Department of Neurology
RECRUITINGSan Francisco, California, 94158, United States
-
University of Colorado Anschutz Medical Campus
RECRUITINGAurora, Colorado, 80045, United States
-
University of Nebraska Medical Center
RECRUITINGOmaha, Nebraska, 68105, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can eye movements reveal the Brain's visual priorities?
- A new eye on the brain: could this tracer unlock Addiction's secrets?
- First look: can a new drug candidate pass early safety tests in humans?
- A painless, contact-free vibration sensor may detect hidden heart and lung problems
- Can a Two-Pathway pill improve ED treatment? a new trial puts the combo to the test
- Could a common drug shield the brain from Alzheimer's?